Geneesmiddelenbeleid
This procedure involves a written consultation report regarding pharmaceutical policy in the Netherlands. It aims to evaluate the current approach to medicine management, pricing, and availability to ensure the healthcare system remains sustainable and effective. This affects healthcare providers, pharmaceutical companies, and patients by potentially altering how medications are procured and funded within the Dutch healthcare system.
National vote coverage: Netherlands-only